Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: A pilot study

Dialysis and Transplantation

Volumn 27, Issue 8, 1998, Pages 498-506

  Caruso, Umberto ^a   Leone, Luciana ^a   Cravotto, Elena ^b   Nava, Demetrio ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; UREMIA;

EID: 0031812347     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990; 300:573-578.
2. Nissenson AR, Nimer SD, Wolcott DL. Recombinant human erythropoietin and renal anemia: Molecular biology, clinical efficacy and nervous system effects. Ann Int Med 1991; 114:402-416.
3. Bieber LL. Carnitine. Am Rev Biochem 1988; 57:261-283.
4. Bohmer T, Bergren H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; i: 126-128.
5. Battistella PA, Angelini C, Vergani L, Bertoli M, Lorenzi S. Carnitine deficiency induced during haemodialysis. Lancet 1978; 1:939.
6. Albertazzi A, Capelli P, Di Paolo B, Pola P, Tondi P, Vaccario O. Endocrine-metabolic effects of L-carnitine in patients on regular dialysis treatment. Proceed EDTA 1982; 19:302-307.
7. Bazzi C, Di Donato S, Castiglione A, Corsi M, D'Amico G. Carnitine metabolism in short- and long-term maintenance hemodialysis. In: Clinical Aspects of Human Carnitine Deficiency, Borum PR (ed.), New York: Pergamon Press, p 245, 1986
8. Savica V, Bellinghieri G, Corvaia E, Di Stefano C, Corsi M, Maccari F, Spagnoli LG, Villaschi S, Palmieri G. Plasma and muscle carnitine levels in hemodialysis patients with morphological-ultrastructural examination of muscle samples Nephron 1983; 35:232-236.
9. Hiatt WR, Koziol BJ, Shapiro JI, Brass EP. Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 1992; 41:1613-1619.
10. Trovato GM, Ginardi V, Di Marco V, Dell'Aira AE, Corsi M. Long-term L-carnitine treatment of chronic anaemia of patients with end-stage renal failure. Curr Ther Res 1982; 31:1042-1049.
11. Vacha GM, Giorcelli G, Siliprandi N, Corsi M. Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 1983; 38:532-540.
12. Bellinghieri G, Savica V, Mallamace A, Ricciardi B, Torre F, Rotondo S, Raneri G, Liosi C, Ilacqua N Lipids and haematocrit after long-term L-carnitine treatment in hemodialysis. 22nd Cong EDTA, June 25-29, 1985, Brussels, Belgium.
13. Labonia WD, Morelli Jr OH, Gimenez MI, Freuler PV, Morelli OH Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 1987; 32:754-759.
14. Donatelli M, Terrizzi C, Zummo G, Russo V, Bucalo ML, Scarpinato A. Effects of L-carnitine on chronic anemia and erythrocyte adenosine triphosphate (ATP) concentration in haemodialysed patients. Curr Ther Res 1987; 41:620-624.
15. Kooistra MP, Struyvenberg A, van Es A. The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 1991; 57:127-128.
16. Matsumura M, Hatakeyama S, Koni I, et al. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 1996; 72:574-578.
17. Bérard E, Iordache A. Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: About two cases. Nephron 1992; 62:368-369.
18. Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 1995; 26:757-764
19. McGarry JD, Foster DW. Free and esterified carnitine: Radio method. In: Methods of Enzymatic Analysis (3rd Ed.), Bergmeyer J, Grabl M (eds.) 1983; VIII:474-481.
20. Sungur C, Sungur A, Akpolat T, et al. Unresponsiveness to human recombinant erythropoietin in an epileptic dialysis patient secondary to valproic acid toxicity. Ann Pharmacother 1992; 26:1156.
21. Millington DS, Bohan TP, Roe CR, et al. Valproylcarnitine: A novel metabolite identified by fast atom bombardment and thermospray liquid chromatography/mass spectrometry. Clinica Chimica Acta 1985; 145:69-76.
22. Lennon DLF, Shrago E, Madden M, Nagle F, Hanson P, Zimmermann S. Carnitine status, plasma lipid profiles and exercise capacity of dialysis patients: Effects of a submaximal exercise program. Metabolism 1986; 35:728-735.
23. Ahmad S, Dasgupta A, Kenny MA. Fatty acid abnormalities in hemodialysis patients: Effects of L-carnitine administration. Kidney Int 1988; 36:5243-5246
24. Kudoh Y, Shoji T, Oimatsu H. The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis. Jap Circ J 1983; 47:1391-1397.
25. Panzetta G, Bonadonna G, Giovene P, De Grandis D. Carnitine kinetics during dialysis: Evidence of unilateral transport from tissues to plasma. Nephron 1985; 41:230-234.
26. Leschke M, Rumpf KW, Eisenhauer T, Fuchs C, Becker K, Kothe U, Scheler F. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int 1983; 24(suppl 16):S143-S146
27. Wanner C, Forstner-Wanner S, Schaeffer G, Schollmeyer P, Horl WH. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Neph 1986; 6:206-211.
28. Casciani CU, Caruso U, Cravotto E, Corsi M, Maccari F. Beneficial effects of L-carnitine in post-dialysis syndrome. Curr Ther Res 1982; 32:116-127.
29. Casciani CU, Caruso U, Cravotto E, Corsi M, Pola P, Savi L, Grilli M. L-carnitine in haemodialysed patients. Arzneim Forsch 1982; 32:293-297.
30. Suzuki Y, Narita M, Yamazaki N. Effects of L-carnitine on arrhythmias during hemodialysis. Jap Heart J 1982; 23:349-359.
31. Panzetta G, Tessitore N, Valvo E, Lupo A, Loschiavo C, Oldrizzi L, Fabris A, Gemmaro L, Rugiu C, Bellotti Z, Maschio G. Improvement of post-dialysis glucose intolerance by carnitine supplementation in dialysis fluid. 22nd Cong. EDTA, June 25-29, 1985, Brussels, Belgium.
32. Vacha GM, Corsi M, Giorcelli G, D'Iddio S, Maccari F. Serum and muscle L-carnitine levels in hemodialyzed patients during and after long-term L-carnitine treatment. Curr Ther Res 1985; 37:505-516.
33. Vacha GM, Corsi M, Giorcelli G, et al. Serum and muscle L-carnitine levels in hemodialyzed patients after L-carnitine long-term treatment and after treatment suspension. In: Immune and Metabolic Aspects of Therapeutic Blood Purification Systems. Proceedings International Symposium, Troudheim. Basel: Karger, pp 225-230, 1985.
34. Taggart EM, Siani G, Stone WJ, Griffis J, Butler B, Borum PR. Carnitine status of adult male hemodialysis patients. In: Clinical Aspects of Human Carnitine Deficiency, Borum PR (ed.). New York: Pergamon Press, pp 246-247, 1986.
35. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirshberg R, Nicora R, Ashbrook DW, Kopple JD. Multicenter trial of L-carnitine in maintenance haemodialysis patients (II). Clinical and biochemical effects. Kidney Int 1990; 38:912-918.
36. van Es A, Henny FC, Kooistra MP, Lobatto S, Scholte HR. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. In: Metabolic and Nutritional Abnormalities in Kidney Disease, Guarnieri G, Panzetta G, Toigo G. (eds.). Contrib Nephrol, Basel: Karger, vol 98, pp 28-35, 1992.
37. Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. J Biol Chem 1992; 267:12673-12681.
38. Arduini A, Rossi M, Mancinelli G, Belfiglio M, Scurti R, Radatti GL, Shohet SB. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sciences 1990; 47:2395-2400.
39. Arduini A, Holme S, Sweeney JD, Dottori S, Sciarroni AF, Calvani M. Addition of L-carnitine to additive solution-suspended red cells stored at 4°C reduces in vitro hemolysis and improves in vivo viability. Transfusion 1997; 37:166-174.
40. Bérard E, Barillon D, Iordache A, Bayle J, Cassuto-Viguier E. Low dose of L-carnitine improves membrane fragility of erythrocytes in hemodialysis patients. Nephron 1994; 68:145